Assessment of endothelial dysfunction: Focus on atherothrombotic disease

被引:44
作者
Blann, AD [1 ]
机构
[1] Univ Birmingham, City Hosp, Dept Med, Haemostasis Thrombosis & Vasc Biol Unit, Birmingham B18 7QH, W Midlands, England
关键词
endothelial cell; von Willebrand factor; flow mediated dilatation; soluble E-selectin; circulating endothelial cells;
D O I
10.1159/000083811
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
As the endothelium is crucial to cardiovascular disease, the accurate assessment of this organ is a valuable tool, especially if such assessments are clinically relevant. As functions of the endothelium focus on haemostasis and the maintenance of correct vascular tone, and dysfunction results in changes that promote thrombosis and hypertension, thus assessment of endothelial function therefore follows these processes. Foremost in the plasma markers of vascular function is von Willebrand factor, a molecule that interacts with platelets. Lack of nitric oxide results in poor blood pressure control that can be quantified by impaired flow mediated dilatation. More recently, increased numbers of circulating endothelial cells have been described that indicate severe damage to the endothelium. Unsurprisingly, these three markers correlate with each other and former two predict adverse outcome in long-term follow up studies. The assessment of vascular damage is becoming recognised as having an increasingly prominent part in the pathophysiology of cardiovascular disease. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:256 / 261
页数:6
相关论文
共 49 条
  • [1] DIFFERENTIATION OF ENDOTHELIAL-CELLS - ANALYSIS OF THE CONSTITUTIVE AND ACTIVATED ENDOTHELIAL-CELL PHENOTYPES
    AUGUSTIN, HG
    KOZIAN, DH
    JOHNSON, RC
    [J]. BIOESSAYS, 1994, 16 (12) : 901 - 906
  • [2] Circulating cell adhesion molecules and death in patients with coronary artery disease
    Blankenberg, S
    Rupprecht, HJ
    Bickel, C
    Peetz, D
    Hafner, G
    Tiret, L
    Meyer, J
    [J]. CIRCULATION, 2001, 104 (12) : 1336 - 1342
  • [3] Von Willebrand factor and soluble E-selectin in hypertension: Influence of treatment and value in predicting the progression of atherosclerosis
    Blann, AD
    Waite, MA
    [J]. CORONARY ARTERY DISEASE, 1996, 7 (02) : 143 - 147
  • [4] Von Willebrand factor and soluble E-selectin in the prediction of cardiovascular disease progression in hyperlipidaemia
    Blann, AD
    Miller, JP
    McCollum, CN
    [J]. ATHEROSCLEROSIS, 1997, 132 (02) : 151 - 156
  • [5] A RELIABLE MARKER OF ENDOTHELIAL-CELL DYSFUNCTION - DOES IT EXIST
    BLANN, AD
    TABERNER, DA
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1995, 90 (02) : 244 - 248
  • [6] Blann AD, 1997, EUR J HAEMATOL, V59, P115
  • [7] Circulating endothelial markers and probability of stroke in haemodialysis patients
    Borawski, J
    Naumnik, B
    Mysliwiec, M
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2003, 14 (03) : 315 - 317
  • [8] Circulating endothelial cells in pulmonary hypertension
    Bull, TM
    Golpon, H
    Hebbel, RR
    Solovey, A
    Cool, CD
    Tuder, RM
    Geraci, MW
    Voelkel, NF
    [J]. THROMBOSIS AND HAEMOSTASIS, 2003, 90 (04) : 698 - 703
  • [9] Endothelial dysfunction: Does it matter? Is it reversible?
    Celermajer, DS
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (02) : 325 - 333
  • [10] Endothelial dysfunction and damage in congestive heart failure - Relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide
    Chong, AY
    Blann, AD
    Patel, J
    Freestone, B
    Hughes, E
    Lip, GYH
    [J]. CIRCULATION, 2004, 110 (13) : 1794 - 1798